PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $62,000 | -28.7% | 16,298 | -4.5% | 0.00% | 0.0% |
| Q4 2019 | $87,000 | +7.4% | 17,072 | +7.0% | 0.00% | 0.0% |
| Q3 2019 | $81,000 | -19.0% | 15,956 | -1.1% | 0.00% | 0.0% |
| Q2 2019 | $100,000 | +66.7% | 16,130 | +24.6% | 0.00% | +100.0% |
| Q1 2019 | $60,000 | +13.2% | 12,943 | +2.9% | 0.00% | -50.0% |
| Q4 2018 | $53,000 | -45.4% | 12,583 | +4.4% | 0.00% | 0.0% |
| Q2 2018 | $97,000 | +27.6% | 12,047 | +18.4% | 0.00% | 0.0% |
| Q1 2018 | $76,000 | +22.6% | 10,172 | -2.4% | 0.00% | 0.0% |
| Q4 2017 | $62,000 | – | 10,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|